Cargando…
SCO‐792, an enteropeptidase inhibitor, improves disease status of diabetes and obesity in mice
AIMS: Enteropeptidase is a serine protease localized on the duodenal brush border that catalyzes the conversion of inactive trypsinogen into active trypsin, thereby regulating protein breakdown in the gut. We evaluated the effects of SCO‐792, a novel enteropeptidase inhibitor, in mice. MATERIALS AND...
Autores principales: | Yashiro, Hiroaki, Hamagami, Kenichi, Hiyoshi, Hideyuki, Sugama, Jun, Tsuchimori, Kazue, Yamaguchi, Fuminari, Moritoh, Yusuke, Sasaki, Minoru, Maekawa, Tsuyoshi, Yamada, Yukio, Watanabe, Masanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771630/ https://www.ncbi.nlm.nih.gov/pubmed/31144422 http://dx.doi.org/10.1111/dom.13799 |
Ejemplares similares
-
Discovery and characterization of a small‐molecule enteropeptidase inhibitor, SCO‐792
por: Sasaki, Masako, et al.
Publicado: (2019) -
An Exploratory Randomized Trial of SCO-792, an Enteropeptidase Inhibitor, in Patients With Type 2 Diabetes and Albuminuria
por: Kagawa, Tomoya, et al.
Publicado: (2022) -
Enteropeptidase inhibitor SCO-792 effectively prevents kidney function decline and fibrosis in a rat model of chronic kidney disease
por: Katayama, Yuko, et al.
Publicado: (2020) -
Design, Synthesis,
and Biological Evaluation of a
Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase
Inhibitors with Low Systemic Exposure for the Treatment of Obesity
por: Ikeda, Zenichi, et al.
Publicado: (2022) -
Role of SCO-792, A Novel Enteropeptidase Inhibitor, In the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
por: Rashid, Mohammed Y, et al.
Publicado: (2021)